Market report
Dermatological drug tenders in Czechia — market report, January 2026
Dermatological drug tenders in Czechia in January 2026: 7,997 tenders published (+20% month on month, +70% year on year), estimated at €214,027 in total, and 8,003 contracts awarded (+20% month on month, +69% year on year), worth €199,923 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,989), Krajská zdravotní, a.s. (837) and Fakultní nemocnice Bulovka (517); most contracts won: ViaPharma s.r.o. (210), ROCHE s.r.o. (197) and AbbVie s.r.o. (133). On average 1.9 bids per contract; 25% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 7,997
- Contracts awarded
- 8,003
- Contract value awarded
- €199,923
- Bids per contract
- 1.9
The highlighted bar is January 2026. Hover a bar for its figure; the table below has every value.
| Figure | January 2026 | December 2025 | Change | January 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 7,997 | 6,652 | +20% | 4,714 | +70% |
| Estimated value | €214,027 | €594,111 | -64% | €584,738 | -63% |
| Buyers | 29 | 32 | -9% | 29 | 0% |
| Contracts awarded | 8,003 | 6,654 | +20% | 4,725 | +69% |
| Contract value (awarded) | €199,923 | €41,768,224 | -100% | €1,390,522 | -86% |
| Winners | 308 | 286 | +8% | 229 | +34% |
| Bids per contract | 1.9 | 2.6 | — | 1.7 | — |
| Single-bid contracts | 25% | 20% | — | 69% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 210 |
| 2 | ROCHE s.r.o. | 197 |
| 3 | AbbVie s.r.o. | 133 |
| 4 | Takeda Pharmaceuticals Czech Republic s.r.o. | 130 |
| 5 | Avenier a.s. | 114 |
| 6 | Janssen-Cilag s.r.o. | 112 |
| 7 | Amgen s.r.o. | 111 |
| 8 | FAGRON a.s. | 86 |
| 9 | BAYER s.r.o. | 75 |
| 10 | Merck Sharp & Dohme s.r.o. | 69 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in January 2026?
- 7,997 (by 29 buyers); for comparison, December 2025: 6,652, January 2025: 4,714.
- Who won the most dermatological drug tenders in Czechia in January 2026?
- By number of contracts: ViaPharma s.r.o. (210), ROCHE s.r.o. (197), AbbVie s.r.o. (133), Takeda Pharmaceuticals Czech Republic s.r.o. (130) and Avenier a.s. (114); 308 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in January 2026?
- Krajská nemocnice T. Bati, a. s. (2,989), Krajská zdravotní, a.s. (837), Fakultní nemocnice Bulovka (517), Fakultní nemocnice Brno (483) and Nemocnice České Budějovice, a.s. (363).
- How competitive were dermatological drug tenders in Czechia in January 2026?
- On average 1.9 bids per contract (12 contracts with a known number of bids); 25% of contracts had a single bid.
- What were the contracts worth in January 2026?
- €199,923 (awarded value, 8,003 contracts); median about €3,100.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.